PER 1.23% 8.0¢ percheron therapeutics limited

next ann:initiation of phase iia trial atl1103, page-17

  1. 18,601 Posts.
    lightbulb Created with Sketch. 4
    I think you get my drift and it's not specific to ANP. You'd think there was a market for the common flu too.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.